Clinical Trial Update: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis [Phase 1]

View source ↗

Summary

A phase 1 safety study of RTA 744 in patients with leptomeningeal carcinomatosis (neoplastic meningitis) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Carcinomatosis

Drugs mentioned

• RTA 744

Snippet

Sponsor: Biogen | Conditions: Leptomeningeal Carcinomatosis | Phase 1 | Status: TERMINATED